Literature DB >> 24199018

Significance of Persistent Nondysplasia Over Multiple Endoscopic Surveillance in Risk Stratification of Patients With Barrett's Esophagus (Gastroenterology 2013;145:548-553, e1).

Jeong Hwan Kim1.   

Abstract

Entities:  

Year:  2013        PMID： 24199018      PMCID： PMC3816192          DOI： 10.5056/jnm.2013.19.4.542

Source DB:  PubMed          Journal:  J Neurogastroenterol Motil        ISSN： 2093-0879            Impact factor:   4.924


× No keyword cloud information.
  10 in total

1.  ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract.

Authors:  William K Hirota; Marc J Zuckerman; Douglas G Adler; Raquel E Davila; James Egan; Jonathan A Leighton; Waqar A Qureshi; Elizabeth Rajan; Robert Fanelli; Jo Wheeler-Harbaugh; Todd H Baron; Douglas O Faigel
Journal:  Gastrointest Endosc       Date:  2006-04       Impact factor: 9.427

2.  Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus.

Authors:  Kenneth K Wang; Richard E Sampliner
Journal:  Am J Gastroenterol       Date:  2008-03       Impact factor: 10.864

3.  The prevalence of and risk factors for Barrett's esophagus in a Korean population: A nationwide multicenter prospective study.

Authors:  Jong-Jae Park; Jae Woo Kim; Hyun Jin Kim; Moon Gi Chung; Seon Mee Park; Gwang Ho Baik; Byung Kyu Nah; Su Youn Nam; Kang Seok Seo; Byung Sung Ko; Jae-Young Jang; Byeong Gwan Kim; Ji Won Kim; Youn Seon Choi; Moon Kyung Joo; Jin Il Kim; Mee-Yon Cho; Nayoung Kim; Soo-Heon Park; Hyun Chae Jung; In-Sik Chung
Journal:  J Clin Gastroenterol       Date:  2009 Nov-Dec       Impact factor: 3.062

4.  Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study.

Authors:  Shivaram Bhat; Helen G Coleman; Fouad Yousef; Brian T Johnston; Damian T McManus; Anna T Gavin; Liam J Murray
Journal:  J Natl Cancer Inst       Date:  2011-06-16       Impact factor: 13.506

5.  American Gastroenterological Association medical position statement on the management of Barrett's esophagus.

Authors:  Stuart J Spechler; Prateek Sharma; Rhonda F Souza; John M Inadomi; Nicholas J Shaheen
Journal:  Gastroenterology       Date:  2011-03       Impact factor: 22.682

6.  The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence.

Authors:  Heiko Pohl; H Gilbert Welch
Journal:  J Natl Cancer Inst       Date:  2005-01-19       Impact factor: 13.506

7.  Incidence of adenocarcinoma among patients with Barrett's esophagus.

Authors:  Frederik Hvid-Jensen; Lars Pedersen; Asbjørn Mohr Drewes; Henrik Toft Sørensen; Peter Funch-Jensen
Journal:  N Engl J Med       Date:  2011-10-13       Impact factor: 91.245

8.  Prevalence of Barrett's esophagus remains low in the Korean population: nationwide cross-sectional prospective multicenter study.

Authors:  In Seok Lee; Suck Chei Choi; Ki Nam Shim; Sam Ryong Jee; Kyu Chan Huh; Jun Haeng Lee; Kwang Jae Lee; Hyung Seok Park; Yong Chan Lee; Hoon Yong Jung; Hyo Jin Park
Journal:  Dig Dis Sci       Date:  2009-10-03       Impact factor: 3.199

Review 9.  Current status of Barrett's esophagus research in Asia.

Authors:  Chi-Yang Chang; Michael B Cook; Yi-Chia Lee; Jaw-Town Lin; Takafumi Ando; Shobna Bhatia; Wong-Ho Chow; Emad M El-Omar; Hidemi Goto; Yang-Qing Li; Kenneth McColl; Nageshwar Reddy; Poong-Lyul Rhee; Prateek Sharma; Joseph J-Y Sung; Uday Ghoshal; Jennie Y-Y Wong; Justin C-Y Wu; Jun Zhang; Khek-Yu Ho
Journal:  J Gastroenterol Hepatol       Date:  2011-02       Impact factor: 4.029

10.  Persistence of nondysplastic Barrett's esophagus identifies patients at lower risk for esophageal adenocarcinoma: results from a large multicenter cohort.

Authors:  Srinivas Gaddam; Mandeep Singh; Gokulakrishnan Balasubramanian; Prashanthi Thota; Neil Gupta; Sachin Wani; April D Higbee; Sharad C Mathur; John D Horwhat; Amit Rastogi; Patrick E Young; Brooks D Cash; Ajay Bansal; John J Vargo; Gary W Falk; David A Lieberman; Richard E Sampliner; Prateek Sharma
Journal:  Gastroenterology       Date:  2013-05-25       Impact factor: 33.883
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.